FIELD: experimental medicine, pharmacology.
SUBSTANCE: invention can be used for the development of a new anti-arrhythmic preparation. Invention proposes application of agonist of delta-2-opiod receptors deltorphin-II as an anti-arrhythmic preparation. Effect of agent is associated with activation of delta-2-opiod receptors.
EFFECT: expanded assortment of agents of designated prescription, valuable medicinal properties.
1 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTI-ARRHYTHMIC AGENT | 2004 |
|
RU2260442C1 |
ANTI-ARRHYTHMIC AGENT | 2005 |
|
RU2320342C2 |
AGENT FOR INCREASING RESISTANCE OF HEART TO ARRYTHMOGENIC ACTION OF ISCHAEMIA AND REPERFUSION | 2014 |
|
RU2587783C1 |
ANTI-ARRHYTHMIC AGENT | 2001 |
|
RU2195275C1 |
AGENT POSSESSING ANTIARRHYTHMIC ACTION | 2019 |
|
RU2700263C1 |
PREPARATION FOR TREATING ARRHYTHMIA | 1998 |
|
RU2163807C2 |
CARDIOPROTECTIVE AND ANTIARRHYTHMIC MEDICINE | 2022 |
|
RU2783444C1 |
ANTIARRHYTHMIC AGENT | 1998 |
|
RU2171115C2 |
GAMMA-HYDROXYPROPYLAMMONIUM-5-HYDROXYNICOTINATE ELICITING ANTI-ISCHEMIC, ANTI-ARRHYTHMIC AND HYPOLIPIDEMIC ACTIVITY | 2003 |
|
RU2245329C1 |
METHOD FOR SIMULATION OF INCREASED STABILITY OF RAT MYOCARDIUM TO ISCHEMIC-REPERFUSION DAMAGE | 2016 |
|
RU2623727C1 |
Authors
Dates
2004-09-10—Published
2003-03-05—Filed